After merging its way onto the Nasdaq last year, kidney disease biotech Chinook Therapeutics is launching a new joint venture in the form of startup SanReno Therapeutics to deepen its footprint in…
After toiling for 40 years, ImmunoGen can now see the potential approval of its first wholly owned oncology drug on the horizon. The biotech is preparing to submit mirvetuximab soravtansine for…
Mei Pharma’s bid to break into a congested market fought over by Bayer and Gilead has yielded data. The pivotal trial linked zandelisib to a 70% response rate in follicular lymphoma patients but…
Fierce Biotech profiles three women breaking barriers in Alzheimer’s disease R&D at leading pharmaceutical companies. Today, Eli Lilly’s donanemab launch leader Brandy Matthews.
The FDA still hasn’t found what its looking for in TG Therapeutics’ application for the leukemia and lymphoma combo treatment nicknamed U2, and so the therapy will be examined at an advisory committee…
MedCity Influencers, Opinion For too long, we’ve forced kids to make do with services made for adults. The results have been nothing less than tragic, as evidenced by today’s pediatric behavioral health crisis. https://medcitynews.com/author/rschneider1
The spinoff, however late, promises to make investments in GE more pure plays, which investors find easier to understand and to value. But for GE Healthcare, the real growth will be in less acute…
The portable MRI machine maker Hyperfine obtained a new clearance from the FDA, adding deep-learning algorithms that can boost the quality of images taken by its scanner-on-wheels.
Deciphera Pharmaceuticals’ corporate restructuring will slash headcount by 35% and stop work on two drug programs. Going forward, the biotech said it will focus on developing drugs that have the potential to be the first or the best in their therapeutic classes.
MedCity Influencers Prescribers need a pharmacogenetics knowledge base to determine a safe and effective medication and dosage for their patients, but they also need pharmacogenetics test information to be easily accessible, interpretable and meaningful. https://medcitynews.com/author/ccheng
